| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.07e-07 | 303 | 22 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.46e-05 | 562 | 22 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.18e-04 | 20 | 22 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.40e-04 | 21 | 22 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.00e-04 | 120 | 22 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.07e-03 | 739 | 22 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.26e-03 | 1160 | 22 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.81e-03 | 1356 | 22 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.74e-03 | 83 | 22 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 3.82e-03 | 84 | 22 | 2 | GO:0003684 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.21e-05 | 136 | 22 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 5.67e-05 | 1390 | 22 | 8 | GO:0045944 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.65e-05 | 596 | 22 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 8.19e-05 | 13 | 22 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.75e-04 | 1377 | 22 | 7 | GO:0140513 | |
| HumanPheno | Hereditary nonpolyposis colorectal carcinoma | 1.23e-05 | 32 | 8 | 3 | HP:0006716 | |
| HumanPheno | Abnormality of the uterus | 1.52e-05 | 256 | 8 | 5 | HP:0000130 | |
| HumanPheno | Dislocated radial head | 6.08e-05 | 54 | 8 | 3 | HP:0003083 | |
| HumanPheno | Abnormality of the radial head | 7.15e-05 | 57 | 8 | 3 | HP:0003995 | |
| HumanPheno | Abnormality of the humeroradial joint | 9.21e-05 | 62 | 8 | 3 | HP:0100744 | |
| HumanPheno | Abnormality of the larynx | 1.08e-04 | 666 | 8 | 6 | HP:0001600 | |
| HumanPheno | Duodenal ulcer | 1.41e-04 | 12 | 8 | 2 | HP:0002588 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 1.41e-04 | 12 | 8 | 2 | HP:0010746 | |
| HumanPheno | Uterine neoplasm | 1.44e-04 | 72 | 8 | 3 | HP:0010784 | |
| HumanPheno | Gastrointestinal carcinoma | 1.63e-04 | 75 | 8 | 3 | HP:0002672 | |
| HumanPheno | Malignant gastrointestinal tract tumors | 1.63e-04 | 75 | 8 | 3 | HP:0006749 | |
| HumanPheno | Abnormal testis morphology | 1.67e-04 | 1129 | 8 | 7 | HP:0000035 | |
| HumanPheno | Female reproductive system neoplasm | 1.69e-04 | 76 | 8 | 3 | HP:0033020 | |
| HumanPheno | Non-obstructive azoospermia | 1.70e-04 | 1132 | 8 | 7 | HP:0011961 | |
| HumanPheno | Azoospermia | 1.97e-04 | 1157 | 8 | 7 | HP:0000027 | |
| HumanPheno | Abnormal stomach morphology | 2.02e-04 | 742 | 8 | 6 | HP:0002577 | |
| HumanPheno | Elbow dislocation | 2.28e-04 | 84 | 8 | 3 | HP:0003042 | |
| HumanPheno | Abnormal spermatogenesis | 2.39e-04 | 1190 | 8 | 7 | HP:0008669 | |
| HumanPheno | Square face | 2.56e-04 | 16 | 8 | 2 | HP:0000321 | |
| HumanPheno | Abnormal duodenum morphology | 2.62e-04 | 88 | 8 | 3 | HP:0002246 | |
| HumanPheno | Abnormal male internal genitalia morphology | 3.20e-04 | 1243 | 8 | 7 | HP:0000022 | |
| HumanPheno | Upper extremity joint dislocation | 3.39e-04 | 96 | 8 | 3 | HP:0030310 | |
| HumanPheno | Neoplasm of the stomach | 3.61e-04 | 98 | 8 | 3 | HP:0006753 | |
| HumanPheno | Functional abnormality of male internal genitalia | 3.68e-04 | 1269 | 8 | 7 | HP:0000025 | |
| HumanPheno | Hypothalamic gonadotropin-releasing hormone deficiency | 4.47e-04 | 21 | 8 | 2 | HP:0003164 | |
| HumanPheno | Localized hirsutism | 4.47e-04 | 21 | 8 | 2 | HP:0009889 | |
| HumanPheno | Abnormal gonadotropin-releasing hormone concentration | 4.47e-04 | 21 | 8 | 2 | HP:0500012 | |
| HumanPheno | Abnormal male reproductive system physiology | 4.66e-04 | 1314 | 8 | 7 | HP:0012874 | |
| HumanPheno | Abnormal male external genitalia morphology | 5.03e-04 | 1329 | 8 | 7 | HP:0000032 | |
| HumanPheno | Abnormal cheek morphology | 5.39e-04 | 282 | 8 | 4 | HP:0004426 | |
| HumanPheno | Neoplasm of the large intestine | 5.63e-04 | 114 | 8 | 3 | HP:0100834 | |
| HumanPheno | Abnormality of the voice | 5.85e-04 | 545 | 8 | 5 | HP:0001608 | |
| HumanPheno | Abnormal external genitalia | 6.22e-04 | 1372 | 8 | 7 | HP:0000811 | |
| HumanPheno | Perimembranous ventricular septal defect | 6.88e-04 | 26 | 8 | 2 | HP:0011682 | |
| HumanPheno | Uterine leiomyosarcoma | 7.99e-04 | 28 | 8 | 2 | HP:0002891 | |
| HumanPheno | Leiomyosarcoma | 7.99e-04 | 28 | 8 | 2 | HP:0100243 | |
| HumanPheno | Neoplasm of the gastrointestinal tract | 8.03e-04 | 313 | 8 | 4 | HP:0007378 | |
| HumanPheno | Long eyelashes | 8.10e-04 | 129 | 8 | 3 | HP:0000527 | |
| HumanPheno | Abnormality of the male genitalia | 8.49e-04 | 1437 | 8 | 7 | HP:0010461 | |
| HumanPheno | Sensorineural hearing impairment | 8.63e-04 | 958 | 8 | 6 | HP:0000407 | |
| HumanPheno | Transitional cell carcinoma of the bladder | 9.81e-04 | 31 | 8 | 2 | HP:0006740 | |
| HumanPheno | Renal neoplasm | 1.01e-03 | 139 | 8 | 3 | HP:0009726 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 1.03e-03 | 140 | 8 | 3 | HP:0001991 | |
| HumanPheno | Neoplasm of the liver | 1.03e-03 | 140 | 8 | 3 | HP:0002896 | |
| HumanPheno | Bimanual synkinesia | 1.05e-03 | 32 | 8 | 2 | HP:0001335 | |
| HumanPheno | Synkinesis | 1.05e-03 | 32 | 8 | 2 | HP:0034980 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 1.11e-03 | 33 | 8 | 2 | HP:0011587 | |
| HumanPheno | Bladder carcinoma | 1.11e-03 | 33 | 8 | 2 | HP:0002862 | |
| HumanPheno | Urinary tract neoplasm | 1.12e-03 | 144 | 8 | 3 | HP:0010786 | |
| HumanPheno | Abnormal internal genitalia | 1.12e-03 | 1498 | 8 | 7 | HP:0000812 | |
| HumanPheno | Bladder neoplasm | 1.18e-03 | 34 | 8 | 2 | HP:0009725 | |
| HumanPheno | Aspiration | 1.18e-03 | 34 | 8 | 2 | HP:0002835 | |
| HumanPheno | Delayed skeletal maturation | 1.26e-03 | 352 | 8 | 4 | HP:0002750 | |
| HumanPheno | Genital neoplasm | 1.26e-03 | 150 | 8 | 3 | HP:0010787 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 1.32e-03 | 36 | 8 | 2 | HP:0010173 | |
| HumanPheno | Unsteady gait | 1.32e-03 | 357 | 8 | 4 | HP:0002317 | |
| HumanPheno | Dyspareunia | 1.40e-03 | 37 | 8 | 2 | HP:0030016 | |
| HumanPheno | Abnormal cerebral ventricle morphology | 1.41e-03 | 1046 | 8 | 6 | HP:0002118 | |
| HumanPheno | Agenesis of corpus callosum | 1.44e-03 | 365 | 8 | 4 | HP:0001274 | |
| HumanPheno | Abnormal uterus morphology | 1.46e-03 | 158 | 8 | 3 | HP:0031105 | |
| HumanPheno | Compulsive behaviors | 1.46e-03 | 158 | 8 | 3 | HP:0000722 | |
| HumanPheno | Abnormal morphology of female internal genitalia | 1.49e-03 | 665 | 8 | 5 | HP:0000008 | |
| HumanPheno | Digestive system neoplasm | 1.58e-03 | 374 | 8 | 4 | HP:0034930 | |
| HumanPheno | Functional abnormality of the inner ear | 1.66e-03 | 1077 | 8 | 6 | HP:0011389 | |
| HumanPheno | Soft tissue sarcoma | 1.69e-03 | 166 | 8 | 3 | HP:0030448 | |
| HumanPheno | Neoplasm by histology | 1.73e-03 | 383 | 8 | 4 | HP:0011792 | |
| HumanPheno | Joint dislocation | 1.85e-03 | 390 | 8 | 4 | HP:0001373 | |
| HumanPheno | Abnormality of the inner ear | 1.89e-03 | 1102 | 8 | 6 | HP:0000359 | |
| HumanPheno | Dysplastic corpus callosum | 1.94e-03 | 395 | 8 | 4 | HP:0006989 | |
| HumanPheno | Abnormality of the upper respiratory tract | 1.98e-03 | 1111 | 8 | 6 | HP:0002087 | |
| HumanPheno | Male hypogonadism | 2.07e-03 | 45 | 8 | 2 | HP:0000026 | |
| HumanPheno | Abnormality of skeletal maturation | 2.13e-03 | 405 | 8 | 4 | HP:0000927 | |
| HumanPheno | Breast hypoplasia | 2.16e-03 | 46 | 8 | 2 | HP:0003187 | |
| HumanPheno | Prominent fingertip pads | 2.16e-03 | 46 | 8 | 2 | HP:0001212 | |
| HumanPheno | Abnormal thyroid morphology | 2.24e-03 | 183 | 8 | 3 | HP:0011772 | |
| HumanPheno | Abnormally high-pitched voice | 2.25e-03 | 47 | 8 | 2 | HP:0001620 | |
| HumanPheno | Prominent digit pad | 2.35e-03 | 48 | 8 | 2 | HP:0011298 | |
| HumanPheno | Abnormality of the female genitalia | 2.46e-03 | 741 | 8 | 5 | HP:0010460 | |
| HumanPheno | Anosmia | 2.55e-03 | 50 | 8 | 2 | HP:0000458 | |
| HumanPheno | Abnormality of mouth size | 2.55e-03 | 425 | 8 | 4 | HP:0011337 | |
| HumanPheno | Obesity | 2.55e-03 | 425 | 8 | 4 | HP:0001513 | |
| HumanPheno | Self-mutilation | 2.65e-03 | 51 | 8 | 2 | HP:0000742 | |
| HumanPheno | Hyposmia | 2.75e-03 | 52 | 8 | 2 | HP:0004409 | |
| HumanPheno | Gastrointestinal ulcer | 2.75e-03 | 52 | 8 | 2 | HP:0034274 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 2.86e-03 | 53 | 8 | 2 | HP:0009906 | |
| HumanPheno | Abnormal hypothalamus physiology | 2.86e-03 | 53 | 8 | 2 | HP:0012285 | |
| HumanPheno | Hypogonadism | 2.88e-03 | 439 | 8 | 4 | HP:0000135 | |
| HumanPheno | Aplasia/Hypoplasia of the corpus callosum | 2.97e-03 | 772 | 8 | 5 | HP:0007370 | |
| HumanPheno | Abnormal palate morphology | 3.06e-03 | 1202 | 8 | 6 | HP:0000174 | |
| HumanPheno | Cryptorchidism | 3.11e-03 | 780 | 8 | 5 | HP:0000028 | |
| HumanPheno | Abnormal cardiac ventricle morphology | 3.11e-03 | 780 | 8 | 5 | HP:0001713 | |
| MousePheno | abnormal trabecula carnea morphology | 8.88e-05 | 78 | 16 | 3 | MP:0004067 | |
| MousePheno | thin myocardium | 1.15e-04 | 85 | 16 | 3 | MP:0002652 | |
| MousePheno | absent olfactory bulb | 1.65e-04 | 17 | 16 | 2 | MP:0003451 | |
| MousePheno | abnormal epicardium morphology | 1.65e-04 | 17 | 16 | 2 | MP:0003057 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 1.86e-04 | 18 | 16 | 2 | MP:0011395 | |
| MousePheno | increased intestinal adenocarcinoma incidence | 2.80e-04 | 22 | 16 | 2 | MP:0002957 | |
| MousePheno | abnormal ventricle myocardium morphology | 2.88e-04 | 116 | 16 | 3 | MP:0010499 | |
| MousePheno | increased intestinal adenoma incidence | 3.63e-04 | 25 | 16 | 2 | MP:0002404 | |
| MousePheno | abnormal hypothalamus physiology | 3.93e-04 | 26 | 16 | 2 | MP:0005645 | |
| MousePheno | abnormal corpus callosum morphology | 3.94e-04 | 129 | 16 | 3 | MP:0000780 | |
| MousePheno | abnormal dorsal telencephalic commissure morphology | 4.21e-04 | 132 | 16 | 3 | MP:0008219 | |
| MousePheno | abnormal muscle physiology | 4.39e-04 | 954 | 16 | 6 | MP:0002106 | |
| MousePheno | abnormal myocardial trabeculae morphology | 5.43e-04 | 144 | 16 | 3 | MP:0002189 | |
| MousePheno | abnormal olfactory lobe morphology | 6.00e-04 | 149 | 16 | 3 | MP:0009944 | |
| MousePheno | lethality, complete penetrance | 6.35e-04 | 33 | 16 | 2 | MP:0011400 | |
| MousePheno | dilated third ventricle | 6.74e-04 | 34 | 16 | 2 | MP:0000827 | |
| MousePheno | abnormal brain commissure morphology | 7.52e-04 | 161 | 16 | 3 | MP:0002199 | |
| MousePheno | respiratory failure | 8.08e-04 | 165 | 16 | 3 | MP:0001953 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 8.54e-04 | 700 | 16 | 5 | MP:0011098 | |
| MousePheno | decreased respiration | 8.81e-04 | 170 | 16 | 3 | MP:0014274 | |
| MousePheno | abnormal myocardium layer morphology | 1.04e-03 | 414 | 16 | 4 | MP:0005329 | |
| MousePheno | perinatal lethality | 1.09e-03 | 1130 | 16 | 6 | MP:0002081 | |
| MousePheno | abnormal heart layer morphology | 1.12e-03 | 422 | 16 | 4 | MP:0010545 | |
| MousePheno | increased megakaryocyte cell number | 1.18e-03 | 45 | 16 | 2 | MP:0008254 | |
| MousePheno | abnormal nervous system tract morphology | 1.20e-03 | 189 | 16 | 3 | MP:0000778 | |
| MousePheno | thin myocardium compact layer | 1.23e-03 | 46 | 16 | 2 | MP:0004057 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 1.34e-03 | 48 | 16 | 2 | MP:0003567 | |
| MousePheno | abnormal brain white matter morphology | 1.53e-03 | 206 | 16 | 3 | MP:0008026 | |
| MousePheno | abnormal trophoblast layer morphology | 1.64e-03 | 211 | 16 | 3 | MP:0005031 | |
| MousePheno | abnormal telencephalon morphology | 1.67e-03 | 812 | 16 | 5 | MP:0000787 | |
| MousePheno | abnormal fetal cardiomyocyte physiology | 1.76e-03 | 55 | 16 | 2 | MP:0011390 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 1.93e-03 | 489 | 16 | 4 | MP:0010630 | |
| MousePheno | decreased erythroid progenitor cell number | 1.96e-03 | 58 | 16 | 2 | MP:0008973 | |
| MousePheno | increased gastrointestinal tumor incidence | 1.96e-03 | 58 | 16 | 2 | MP:0010279 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.99e-03 | 1269 | 16 | 6 | MP:0011111 | |
| MousePheno | cyanosis | 2.00e-03 | 226 | 16 | 3 | MP:0001575 | |
| MousePheno | abnormal embryonic growth/weight/body size | 2.21e-03 | 1295 | 16 | 6 | MP:0002088 | |
| MousePheno | abnormal fibroblast apoptosis | 2.23e-03 | 62 | 16 | 2 | MP:0013500 | |
| MousePheno | embryonic lethality during organogenesis | 2.33e-03 | 876 | 16 | 5 | MP:0006207 | |
| MousePheno | increased alimentary system tumor incidence | 2.45e-03 | 65 | 16 | 2 | MP:0010292 | |
| MousePheno | abnormal respiratory system physiology | 2.59e-03 | 897 | 16 | 5 | MP:0002133 | |
| MousePheno | abnormal myocardium compact layer morphology | 2.60e-03 | 67 | 16 | 2 | MP:0004056 | |
| MousePheno | abnormal oxygen level | 2.85e-03 | 256 | 16 | 3 | MP:0001574 | |
| MousePheno | ventricle myocardium hypoplasia | 2.91e-03 | 71 | 16 | 2 | MP:0010502 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 3.24e-03 | 268 | 16 | 3 | MP:0011108 | |
| MousePheno | abnormal fibroblast physiology | 3.35e-03 | 271 | 16 | 3 | MP:0020414 | |
| MousePheno | abnormal embryo size | 3.42e-03 | 956 | 16 | 5 | MP:0001697 | |
| MousePheno | abnormal third ventricle morphology | 3.51e-03 | 78 | 16 | 2 | MP:0000826 | |
| MousePheno | abnormal palatal shelf fusion at midline | 3.68e-03 | 80 | 16 | 2 | MP:0009887 | |
| MousePheno | abnormal brain ventricle morphology | 3.89e-03 | 286 | 16 | 3 | MP:0000822 | |
| MousePheno | abnormal somatic nervous system physiology | 3.96e-03 | 83 | 16 | 2 | MP:0005423 | |
| MousePheno | abnormal respiration | 4.00e-03 | 598 | 16 | 4 | MP:0001943 | |
| MousePheno | abnormal gas homeostasis | 4.05e-03 | 600 | 16 | 4 | MP:0003948 | |
| MousePheno | myocardium hypoplasia | 4.24e-03 | 86 | 16 | 2 | MP:0010500 | |
| MousePheno | abnormal megakaryocyte morphology | 4.24e-03 | 86 | 16 | 2 | MP:0002417 | |
| MousePheno | abnormal prenatal growth/weight/body size | 4.57e-03 | 1493 | 16 | 6 | MP:0004196 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.20e-06 | 2 | 21 | 2 | IPR024670 | |
| Domain | BCL9 | 1.20e-06 | 2 | 21 | 2 | PF11502 | |
| Domain | Bcl-9 | 1.20e-06 | 2 | 21 | 2 | IPR015668 | |
| Domain | Znf_FYVE_PHD | 1.17e-02 | 147 | 21 | 2 | IPR011011 | |
| Domain | Homeobox_CS | 1.83e-02 | 186 | 21 | 2 | IPR017970 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.46e-08 | 26 | 19 | 4 | MM14793 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 5.85e-06 | 91 | 19 | 4 | M27101 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.31e-05 | 42 | 19 | 3 | M27272 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 5.16e-05 | 158 | 19 | 4 | MM14791 | |
| Pathway | WNT_SIGNALING | 2.19e-04 | 89 | 19 | 3 | M5493 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.32e-04 | 233 | 19 | 4 | M27099 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.56e-04 | 239 | 19 | 4 | MM14756 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.60e-04 | 18 | 19 | 2 | M26942 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 5.49e-04 | 26 | 19 | 2 | M39407 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 6.84e-04 | 29 | 19 | 2 | M48076 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 6.84e-04 | 29 | 19 | 2 | M39890 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 8.65e-04 | 330 | 19 | 4 | M7847 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.11e-03 | 37 | 19 | 2 | M27797 | |
| Pubmed | 1.75e-09 | 83 | 22 | 5 | 28794006 | ||
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 2.19e-09 | 5 | 22 | 3 | 30760710 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 2.19e-09 | 5 | 22 | 3 | 32808927 | |
| Pubmed | 4.39e-09 | 6 | 22 | 3 | 15574752 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 4.39e-09 | 6 | 22 | 3 | 25184676 | |
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 30366904 | ||
| Pubmed | 1.33e-08 | 268 | 22 | 6 | 33640491 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.59e-08 | 351 | 22 | 6 | 38297188 | |
| Pubmed | 7.96e-08 | 14 | 22 | 3 | 28174279 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.11e-07 | 457 | 22 | 6 | 32344865 | |
| Pubmed | Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. | 3.82e-07 | 2 | 22 | 2 | 18498752 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 20682801 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 38811552 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 33767438 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 15371335 | ||
| Pubmed | Pygopus residues required for its binding to Legless are critical for transcription and development. | 1.15e-06 | 3 | 22 | 2 | 14612447 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 34545187 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 33649334 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 20637214 | ||
| Pubmed | 1.52e-06 | 1429 | 22 | 8 | 35140242 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 11955446 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12754253 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 19699733 | ||
| Pubmed | 2.74e-06 | 157 | 22 | 4 | 30186101 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 17052462 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 11912212 | ||
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 3.82e-06 | 5 | 22 | 2 | 24360964 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 28103279 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 14988403 | ||
| Pubmed | CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis. | 3.82e-06 | 5 | 22 | 2 | 24939902 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 19328798 | ||
| Pubmed | Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. | 5.72e-06 | 6 | 22 | 2 | 30760720 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 17113272 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 11443112 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 21399610 | ||
| Pubmed | 5.91e-06 | 425 | 22 | 5 | 24999758 | ||
| Pubmed | 9.81e-06 | 472 | 22 | 5 | 38943005 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 24239381 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 10823961 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 1.07e-05 | 8 | 22 | 2 | 28296634 | |
| Pubmed | 1.62e-05 | 78 | 22 | 3 | 28611094 | ||
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 31073027 | ||
| Pubmed | 2.49e-05 | 90 | 22 | 3 | 19515997 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 12189208 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 24009623 | ||
| Pubmed | FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. | 3.46e-05 | 14 | 22 | 2 | 12571102 | |
| Pubmed | 4.16e-05 | 638 | 22 | 5 | 31182584 | ||
| Pubmed | 4.56e-05 | 16 | 22 | 2 | 23870121 | ||
| Pubmed | 4.56e-05 | 16 | 22 | 2 | 22792322 | ||
| Pubmed | 4.84e-05 | 1103 | 22 | 6 | 34189442 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 4.92e-05 | 113 | 22 | 3 | 34474245 | |
| Pubmed | 5.16e-05 | 17 | 22 | 2 | 28291835 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.78e-05 | 341 | 22 | 4 | 32971831 | |
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 20602751 | ||
| Pubmed | 6.80e-05 | 126 | 22 | 3 | 16284245 | ||
| Pubmed | Development of midline cell types and commissural axon tracts requires Fgfr1 in the cerebrum. | 7.21e-05 | 20 | 22 | 2 | 16309667 | |
| Pubmed | 7.21e-05 | 20 | 22 | 2 | 11877444 | ||
| Pubmed | 7.96e-05 | 21 | 22 | 2 | 19596656 | ||
| Pubmed | Sox2 modulates the function of two distinct cell lineages in mouse skin. | 7.96e-05 | 21 | 22 | 2 | 23948231 | |
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 22748019 | ||
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 27407143 | ||
| Pubmed | 1.01e-04 | 144 | 22 | 3 | 30585266 | ||
| Pubmed | 1.03e-04 | 396 | 22 | 4 | 26687479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.05e-04 | 398 | 22 | 4 | 35016035 | |
| Pubmed | 1.14e-04 | 25 | 22 | 2 | 29379870 | ||
| Pubmed | 1.19e-04 | 152 | 22 | 3 | 38360978 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.95e-04 | 180 | 22 | 3 | 35198878 | |
| Pubmed | 1.99e-04 | 33 | 22 | 2 | 20301390 | ||
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 2.12e-04 | 34 | 22 | 2 | 30894540 | |
| Pubmed | 2.24e-04 | 35 | 22 | 2 | 23192594 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.94e-04 | 40 | 22 | 2 | 34585037 | |
| Pubmed | 3.52e-04 | 220 | 22 | 3 | 24550385 | ||
| Pubmed | 3.58e-04 | 549 | 22 | 4 | 38280479 | ||
| Pubmed | 3.89e-04 | 46 | 22 | 2 | 20301533 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.47e-04 | 582 | 22 | 4 | 20467437 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.50e-04 | 583 | 22 | 4 | 29844126 | |
| Pubmed | Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 4.59e-04 | 50 | 22 | 2 | 27716508 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.89e-04 | 1082 | 22 | 5 | 38697112 | |
| Pubmed | 5.56e-04 | 55 | 22 | 2 | 35945219 | ||
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 5.76e-04 | 56 | 22 | 2 | 29184203 | |
| Pubmed | Parallel Pbx-Dependent Pathways Govern the Coalescence and Fate of Motor Columns. | 6.18e-04 | 58 | 22 | 2 | 27568519 | |
| Interaction | SP7 interactions | 6.51e-10 | 304 | 22 | 8 | int:SP7 | |
| Interaction | PAX9 interactions | 4.40e-09 | 130 | 22 | 6 | int:PAX9 | |
| Interaction | EGR2 interactions | 2.28e-08 | 171 | 22 | 6 | int:EGR2 | |
| Interaction | SOX9 interactions | 5.74e-08 | 97 | 22 | 5 | int:SOX9 | |
| Interaction | TBR1 interactions | 1.24e-07 | 113 | 22 | 5 | int:TBR1 | |
| Interaction | TBXT interactions | 1.41e-07 | 116 | 22 | 5 | int:TBXT | |
| Interaction | AR interactions | 4.55e-07 | 992 | 22 | 9 | int:AR | |
| Interaction | SSBP4 interactions | 4.66e-07 | 59 | 22 | 4 | int:SSBP4 | |
| Interaction | TLX3 interactions | 5.29e-07 | 291 | 22 | 6 | int:TLX3 | |
| Interaction | LHX4 interactions | 8.39e-07 | 166 | 22 | 5 | int:LHX4 | |
| Interaction | TLX1 interactions | 1.09e-06 | 175 | 22 | 5 | int:TLX1 | |
| Interaction | LHX2 interactions | 1.36e-06 | 183 | 22 | 5 | int:LHX2 | |
| Interaction | GATA2 interactions | 2.05e-06 | 199 | 22 | 5 | int:GATA2 | |
| Interaction | GSC interactions | 2.23e-06 | 87 | 22 | 4 | int:GSC | |
| Interaction | FEV interactions | 2.26e-06 | 203 | 22 | 5 | int:FEV | |
| Interaction | SOX10 interactions | 2.79e-06 | 92 | 22 | 4 | int:SOX10 | |
| Interaction | SOX17 interactions | 3.18e-06 | 95 | 22 | 4 | int:SOX17 | |
| Interaction | ERG interactions | 3.58e-06 | 223 | 22 | 5 | int:ERG | |
| Interaction | PYGO1 interactions | 3.63e-06 | 28 | 22 | 3 | int:PYGO1 | |
| Interaction | NUP35 interactions | 4.69e-06 | 424 | 22 | 6 | int:NUP35 | |
| Interaction | SSBP2 interactions | 4.73e-06 | 105 | 22 | 4 | int:SSBP2 | |
| Interaction | PAX8 interactions | 5.91e-06 | 111 | 22 | 4 | int:PAX8 | |
| Interaction | CRX interactions | 6.76e-06 | 254 | 22 | 5 | int:CRX | |
| Interaction | LDB1 interactions | 6.80e-06 | 115 | 22 | 4 | int:LDB1 | |
| Interaction | PAX7 interactions | 9.17e-06 | 124 | 22 | 4 | int:PAX7 | |
| Interaction | ISL1 interactions | 1.17e-05 | 41 | 22 | 3 | int:ISL1 | |
| Interaction | ISL2 interactions | 1.17e-05 | 41 | 22 | 3 | int:ISL2 | |
| Interaction | BCL9L interactions | 1.89e-05 | 48 | 22 | 3 | int:BCL9L | |
| Interaction | ORC6 interactions | 2.01e-05 | 49 | 22 | 3 | int:ORC6 | |
| Interaction | PAX6 interactions | 3.92e-05 | 366 | 22 | 5 | int:PAX6 | |
| Interaction | ALG13 interactions | 4.23e-05 | 183 | 22 | 4 | int:ALG13 | |
| Interaction | LHX3 interactions | 4.42e-05 | 185 | 22 | 4 | int:LHX3 | |
| Interaction | GATA3 interactions | 4.61e-05 | 187 | 22 | 4 | int:GATA3 | |
| Interaction | HNF1B interactions | 4.90e-05 | 190 | 22 | 4 | int:HNF1B | |
| Interaction | GCM1 interactions | 5.40e-05 | 68 | 22 | 3 | int:GCM1 | |
| Interaction | KLF5 interactions | 5.42e-05 | 195 | 22 | 4 | int:KLF5 | |
| Interaction | ETV4 interactions | 5.65e-05 | 69 | 22 | 3 | int:ETV4 | |
| Interaction | ASCL2 interactions | 8.81e-05 | 13 | 22 | 2 | int:ASCL2 | |
| Interaction | SOX7 interactions | 9.46e-05 | 82 | 22 | 3 | int:SOX7 | |
| Interaction | PAX2 interactions | 1.05e-04 | 85 | 22 | 3 | int:PAX2 | |
| Interaction | IRF4 interactions | 1.05e-04 | 85 | 22 | 3 | int:IRF4 | |
| Interaction | BCL9 interactions | 1.09e-04 | 86 | 22 | 3 | int:BCL9 | |
| Interaction | SNW1 interactions | 1.14e-04 | 747 | 22 | 6 | int:SNW1 | |
| Interaction | PCAT1 interactions | 1.18e-04 | 15 | 22 | 2 | int:PCAT1 | |
| Interaction | FOXI1 interactions | 1.33e-04 | 92 | 22 | 3 | int:FOXI1 | |
| Interaction | ASF1A interactions | 1.40e-04 | 249 | 22 | 4 | int:ASF1A | |
| Interaction | NANOG interactions | 1.43e-04 | 481 | 22 | 5 | int:NANOG | |
| Interaction | LHX1 interactions | 1.86e-04 | 103 | 22 | 3 | int:LHX1 | |
| Interaction | HNF4A interactions | 2.04e-04 | 275 | 22 | 4 | int:HNF4A | |
| Interaction | POU3F2 interactions | 2.14e-04 | 20 | 22 | 2 | int:POU3F2 | |
| Interaction | EN1 interactions | 2.26e-04 | 110 | 22 | 3 | int:EN1 | |
| Interaction | RBBP5 interactions | 2.41e-04 | 287 | 22 | 4 | int:RBBP5 | |
| Interaction | TERF2IP interactions | 2.71e-04 | 552 | 22 | 5 | int:TERF2IP | |
| Interaction | PPARD interactions | 2.71e-04 | 117 | 22 | 3 | int:PPARD | |
| Interaction | HOXD10 interactions | 2.84e-04 | 23 | 22 | 2 | int:HOXD10 | |
| Interaction | SSBP3 interactions | 2.85e-04 | 119 | 22 | 3 | int:SSBP3 | |
| Interaction | FOS interactions | 3.31e-04 | 312 | 22 | 4 | int:FOS | |
| Interaction | POU5F1 interactions | 3.51e-04 | 584 | 22 | 5 | int:POU5F1 | |
| Interaction | SLC30A5 interactions | 3.95e-04 | 133 | 22 | 3 | int:SLC30A5 | |
| Interaction | SOX15 interactions | 4.68e-04 | 141 | 22 | 3 | int:SOX15 | |
| Interaction | TLX2 interactions | 4.78e-04 | 142 | 22 | 3 | int:TLX2 | |
| Interaction | HOXD4 interactions | 4.86e-04 | 30 | 22 | 2 | int:HOXD4 | |
| Interaction | SNRNP40 interactions | 5.23e-04 | 637 | 22 | 5 | int:SNRNP40 | |
| Interaction | ELF5 interactions | 5.29e-04 | 147 | 22 | 3 | int:ELF5 | |
| Interaction | NR1H4 interactions | 5.53e-04 | 32 | 22 | 2 | int:NR1H4 | |
| Interaction | ARID2 interactions | 5.94e-04 | 153 | 22 | 3 | int:ARID2 | |
| Interaction | LMO4 interactions | 6.65e-04 | 159 | 22 | 3 | int:LMO4 | |
| Interaction | TLE3 interactions | 6.68e-04 | 376 | 22 | 4 | int:TLE3 | |
| Interaction | KLF4 interactions | 6.77e-04 | 160 | 22 | 3 | int:KLF4 | |
| Interaction | E2F5 interactions | 7.01e-04 | 36 | 22 | 2 | int:E2F5 | |
| Interaction | HOXB2 interactions | 7.01e-04 | 36 | 22 | 2 | int:HOXB2 | |
| Interaction | TBC1D2 interactions | 7.40e-04 | 37 | 22 | 2 | int:TBC1D2 | |
| Interaction | GATA1 interactions | 8.21e-04 | 171 | 22 | 3 | int:GATA1 | |
| Interaction | TEAD1 interactions | 8.92e-04 | 176 | 22 | 3 | int:TEAD1 | |
| Interaction | SUPT5H interactions | 9.07e-04 | 408 | 22 | 4 | int:SUPT5H | |
| Interaction | FKBP5 interactions | 9.57e-04 | 414 | 22 | 4 | int:FKBP5 | |
| Interaction | MDC1 interactions | 9.57e-04 | 414 | 22 | 4 | int:MDC1 | |
| Interaction | HEMGN interactions | 1.05e-03 | 44 | 22 | 2 | int:HEMGN | |
| Interaction | THRB interactions | 1.05e-03 | 186 | 22 | 3 | int:THRB | |
| Interaction | TFIP11 interactions | 1.07e-03 | 427 | 22 | 4 | int:TFIP11 | |
| Interaction | NFIA interactions | 1.08e-03 | 188 | 22 | 3 | int:NFIA | |
| Interaction | RORC interactions | 1.09e-03 | 45 | 22 | 2 | int:RORC | |
| Interaction | MYOD1 interactions | 1.18e-03 | 194 | 22 | 3 | int:MYOD1 | |
| Interaction | PYGO2 interactions | 1.24e-03 | 48 | 22 | 2 | int:PYGO2 | |
| Interaction | NR1I2 interactions | 1.24e-03 | 48 | 22 | 2 | int:NR1I2 | |
| Interaction | PRPS1 interactions | 1.27e-03 | 199 | 22 | 3 | int:PRPS1 | |
| Interaction | E2F1 interactions | 1.29e-03 | 200 | 22 | 3 | int:E2F1 | |
| Interaction | USP43 interactions | 1.46e-03 | 52 | 22 | 2 | int:USP43 | |
| Interaction | HES6 interactions | 1.46e-03 | 52 | 22 | 2 | int:HES6 | |
| Interaction | LHX8 interactions | 1.52e-03 | 53 | 22 | 2 | int:LHX8 | |
| Interaction | CAPN1 interactions | 1.59e-03 | 215 | 22 | 3 | int:CAPN1 | |
| Interaction | LDB2 interactions | 1.69e-03 | 56 | 22 | 2 | int:LDB2 | |
| Interaction | TPRX2 interactions | 1.69e-03 | 56 | 22 | 2 | int:TPRX2 | |
| Interaction | DUS3L interactions | 1.69e-03 | 56 | 22 | 2 | int:DUS3L | |
| Interaction | CEBPA interactions | 1.74e-03 | 1245 | 22 | 6 | int:CEBPA | |
| Interaction | NOP14 interactions | 1.74e-03 | 222 | 22 | 3 | int:NOP14 | |
| Interaction | SRSF9 interactions | 1.78e-03 | 224 | 22 | 3 | int:SRSF9 | |
| Interaction | LHX6 interactions | 1.81e-03 | 58 | 22 | 2 | int:LHX6 | |
| Interaction | NR1H3 interactions | 1.81e-03 | 58 | 22 | 2 | int:NR1H3 | |
| GeneFamily | WD repeat domain containing | 1.47e-02 | 262 | 13 | 2 | 362 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 2.16e-05 | 200 | 22 | 4 | M4352 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 4.29e-05 | 989 | 22 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.05e-06 | 159 | 22 | 4 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.55e-06 | 199 | 22 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.94e-05 | 185 | 22 | 3 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 9.94e-05 | 185 | 22 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 190 | 22 | 3 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | facs-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 192 | 22 | 3 | 1f81b356520b5506051383d37fae204d59795336 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 7.32e-06 | 51 | 22 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | irritable bowel syndrome | 1.24e-04 | 131 | 22 | 3 | EFO_0000555 | |
| Disease | response to mTOR inhibitor | 1.58e-04 | 25 | 22 | 2 | EFO_0005417 | |
| Disease | Kallmann Syndrome | 1.71e-04 | 26 | 22 | 2 | C0162809 | |
| Disease | taste liking measurement | 1.79e-04 | 388 | 22 | 4 | EFO_0010155 | |
| Disease | Colorectal cancer | 1.84e-04 | 27 | 22 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 1.84e-04 | 27 | 22 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 1.84e-04 | 27 | 22 | 2 | cv:C0009404 | |
| Disease | Breast adenocarcinoma | 4.28e-04 | 41 | 22 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.28e-04 | 41 | 22 | 2 | C0496956 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.30e-04 | 200 | 22 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | pneumonia | 5.62e-04 | 47 | 22 | 2 | EFO_0003106 | |
| Disease | Diffuse Large B-Cell Lymphoma | 7.69e-04 | 55 | 22 | 2 | C0079744 | |
| Disease | Endometrial Neoplasms | 8.55e-04 | 58 | 22 | 2 | C0014170 | |
| Disease | Malignant neoplasm of breast | 9.94e-04 | 1074 | 22 | 5 | C0006142 | |
| Disease | Colorectal Neoplasms | 1.10e-03 | 277 | 22 | 3 | C0009404 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.17e-03 | 68 | 22 | 2 | EFO_0007826, EFO_0007860 | |
| Disease | Endometrial Carcinoma | 1.31e-03 | 72 | 22 | 2 | C0476089 | |
| Disease | Self-injurious behavior | 1.54e-03 | 78 | 22 | 2 | HP_0100716 | |
| Disease | Colorectal Carcinoma | 1.65e-03 | 702 | 22 | 4 | C0009402 | |
| Disease | Adenocarcinoma of large intestine | 2.32e-03 | 96 | 22 | 2 | C1319315 | |
| Disease | gastroesophageal reflux disease | 2.56e-03 | 101 | 22 | 2 | EFO_0003948 | |
| Disease | neurotic disorder | 2.56e-03 | 101 | 22 | 2 | EFO_0004257 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 3.10e-03 | 398 | 22 | 3 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | colorectal cancer (is_implicated_in) | 3.65e-03 | 121 | 22 | 2 | DOID:9256 (is_implicated_in) | |
| Disease | mood instability measurement | 4.07e-03 | 128 | 22 | 2 | EFO_0008475 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGLQPPTMPGQQGVH | 2111 | Q09472 | |
| NHAETLDPPGMGGPQ | 751 | A0A096LP49 | |
| AGGGAPQPGPDMEQP | 226 | Q8NFD5 | |
| PQPGPDMEQPQHGGA | 231 | Q8NFD5 | |
| GPPAQGHPQHMQQMG | 176 | Q9P2D1 | |
| VQGGMALPPPPHGHE | 21 | P40426 | |
| NEPPIGQMHPPHGSV | 1076 | P43146 | |
| QPGPHSQSGPGAPMK | 951 | Q9Y6V0 | |
| MSPSPGASGGHQPQP | 141 | Q03052 | |
| SPEPQPNPGGKMEGE | 391 | Q2M2Z5 | |
| PQRPQMPGHSGPGGE | 581 | A8MVW0 | |
| PGPSPHMAQQHGDPA | 791 | Q14686 | |
| NAVGPNIPPHGVPMG | 1096 | O00512 | |
| HEVPGHPPGGDMGQQ | 486 | Q86UU0 | |
| PAPPGFGPEHMGDLQ | 151 | P28340 | |
| NQPHPFPQNPLGMGF | 126 | Q9Y3Y4 | |
| PSGQMPDNPPHRNRG | 226 | Q8WUJ1 | |
| PAPGMHPQAPGVHPQ | 396 | Q15428 | |
| GNMPDVPSHPQDPQG | 61 | O95167 | |
| MEGSGEQPGPQPQHP | 1 | Q9UJA5 | |
| PPQGLPRPQDMHGPQ | 661 | Q9C0J8 | |
| ENPPPPGFIMHGNVN | 836 | O94979 | |
| GPGPSGEQPMEGSHQ | 1441 | Q702N8 |